Science & Technology
Mon, June 20, 2011Sun, June 19, 2011Sat, June 18, 2011Fri, June 17, 2011Thu, June 16, 2011Bull & Lifshitz, LLP Announces Investigation of Ness Technologies, Inc.
//science-technology.news-articles.net/content/2 .. nces-investigation-of-ness-technologies-inc.html
Published in Science and Technology on Saturday, June 18th 2011 at 10:05 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
NEW YORK--([ BUSINESS WIRE ])--Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Ness Technologies, Inc. (NASDAQ: NSTC) (referred to as "Ness" or the aCompanya) to an affiliate of Citi Venture Capital International in an all-cash transaction valued at approximately $307 million.
Under the terms of the agreement, Ness stockholders will receive $7.75 for each share of common stock they hold.
Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Companya™s shareholders.
If you are a holder of Ness common stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.
If you are a shareholder of Ness and would like more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: [ counsel@nyclasslaw.com ]. All e-mail correspondence should make reference to Ness.
Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at [ www.nyclasslaw.com ].
ATTORNEY ADVERTISING. © 2011 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter.